Project Number 1R21AG068546-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Reversal of neurodegeneration through pTau clearance by chimeric scavenger receptor monocytes Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau b. Tau Phosphorylation, Metabolism, and Assembly Researcher and Organization Principal Investigator CURRAN, MICHAEL A Principal Investigator First Name MICHAEL Principal Investigator Last Name CURRAN Awardee Organization UNIVERSITY OF TX MD ANDERSON CAN CTR Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-053: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) FY Overall Cost $445,500 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
